Format

Send to

Choose Destination
Cold Spring Harb Perspect Med. 2013 Jun 1;3(6). pii: a012146. doi: 10.1101/cshperspect.a012146.

The "stop" and "go" of nicotine dependence: role of GABA and glutamate.

Author information

1
Department of Psychiatry, School of Medicine, University of California San Diego, La Jolla, California 92093, USA.

Abstract

Nicotine plays an important role in the initiation and maintenance of tobacco smoking. Importantly, chronic nicotine exposure alters the function of brain reward systems, resulting in the development of a nicotine-dependent state. This nicotine-dependent state is associated with aversive affective and somatic signs upon abstinence from smoking, often leading to relapse in abstinent smokers. This article reviews the role of the major excitatory and inhibitory neurotransmitters glutamate and γ-aminobutyric acid (GABA), respectively, in both the reinforcing effects of nicotine and development of nicotine dependence. Evidence suggests that blockade of glutamatergic neurotransmission attenuates both nicotine intake and nicotine seeking. In contrast, both nicotine intake and nicotine seeking are attenuated when GABA neurotransmission is facilitated. In conclusion, medications that either attenuate/negatively modulate glutamatergic neurotransmission or facilitate/positively modulate GABA neurotransmission may be useful for promoting smoking cessation in humans.

PMID:
23732855
PMCID:
PMC3662348
DOI:
10.1101/cshperspect.a012146
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center